CONSUN PHARMA (01681) Revenue Breakdown - Main Composition

14.920
-0.760-4.85%

Trading May 7 15:52 CST

12.56BMarket Cap10.52P/E (TTM)

CONSUN PHARMA (01681) Revenue Breakdown Overview

By Business/Source

Currency:CNY

2025/FY

Stock NameRevenueRatio

Kangchen Pharmaceutical Division2.97B86.81%

Yulin Pharmaceutical Division450.85M13.19%

By Product

Currency:CNY

2025/FY

Stock NameRevenueRatio

Renal drugs2.4B70.30%

Women and children medicine375.73M10.99%

医用成像对比剂236.85M6.93%

Orthopedic drugs188.37M5.51%

Dermatologic drugs121.21M3.55%

Hepatobiliary drugs68.28M2.00%

Other24.62M0.72%

View all

By Country/Region

Currency:CNY

2025/FY

Stock NameRevenueRatio

China Mainland3.38B99.00%

Other areas34.17M1.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"